| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 7.69e-07 | 16 | 93 | 4 | GO:0004697 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 7.69e-07 | 16 | 93 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.48e-06 | 21 | 93 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.26e-05 | 110 | 93 | 6 | GO:0008238 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.81e-05 | 85 | 93 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.05e-04 | 20 | 93 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | carnitine O-palmitoyltransferase activity | 1.28e-04 | 4 | 93 | 2 | GO:0004095 | |
| GeneOntologyMolecularFunction | all-trans retinal binding | 2.13e-04 | 5 | 93 | 2 | GO:0005503 | |
| GeneOntologyMolecularFunction | O-palmitoyltransferase activity | 2.13e-04 | 5 | 93 | 2 | GO:0016416 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.40e-04 | 65 | 93 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | carnitine O-acyltransferase activity | 3.18e-04 | 6 | 93 | 2 | GO:0016406 | |
| GeneOntologyMolecularFunction | coreceptor activity | 3.56e-04 | 72 | 93 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 4.16e-04 | 207 | 93 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | 11-cis retinal binding | 4.44e-04 | 7 | 93 | 2 | GO:0005502 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 4.72e-04 | 212 | 93 | 6 | GO:0017171 | |
| GeneOntologyMolecularFunction | protein kinase activity | 4.79e-04 | 600 | 93 | 10 | GO:0004672 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 5.27e-04 | 34 | 93 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | alcohol transmembrane transporter activity | 5.90e-04 | 8 | 93 | 2 | GO:0015665 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 5.90e-04 | 8 | 93 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 6.69e-04 | 85 | 93 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | frizzled binding | 9.84e-04 | 42 | 93 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor | 1.15e-03 | 11 | 93 | 2 | GO:0016670 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 1.37e-03 | 12 | 93 | 2 | GO:0008239 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 1.54e-03 | 49 | 93 | 3 | GO:0004180 | |
| GeneOntologyMolecularFunction | protease binding | 1.58e-03 | 181 | 93 | 5 | GO:0002020 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.70e-03 | 709 | 93 | 10 | GO:0016773 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.96e-03 | 190 | 93 | 5 | GO:0004252 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase regulator activity | 2.47e-03 | 16 | 93 | 2 | GO:0046935 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 2.62e-03 | 123 | 93 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | kinase activity | 2.92e-03 | 764 | 93 | 10 | GO:0016301 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 3.03e-03 | 305 | 93 | 6 | GO:0019207 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.42e-03 | 654 | 93 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | retinal binding | 4.25e-03 | 21 | 93 | 2 | GO:0016918 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 4.73e-03 | 145 | 93 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 4.99e-03 | 74 | 93 | 3 | GO:0005548 | |
| GeneOntologyCellularComponent | cell surface | SELL PROM1 FAP PRSS8 NTRK2 ROR2 LRP1 LRP2 LRP4 LRP6 ITGA2B ADTRP DSCAML1 MUSK CTSZ ENOX2 | 2.90e-05 | 1111 | 93 | 16 | GO:0009986 |
| Domain | Ldl_recept_b | 4.01e-09 | 14 | 88 | 5 | PF00058 | |
| Domain | LDLRB | 4.01e-09 | 14 | 88 | 5 | PS51120 | |
| Domain | LY | 5.99e-09 | 15 | 88 | 5 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.99e-09 | 15 | 88 | 5 | IPR000033 | |
| Domain | EGF | 7.91e-09 | 126 | 88 | 9 | PF00008 | |
| Domain | Pkinase_C | 1.90e-08 | 37 | 88 | 6 | IPR017892 | |
| Domain | Pkinase_C | 4.21e-08 | 42 | 88 | 6 | PF00433 | |
| Domain | AGC-kinase_C | 2.47e-07 | 56 | 88 | 6 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.47e-07 | 56 | 88 | 6 | PS51285 | |
| Domain | S_TK_X | 2.47e-07 | 56 | 88 | 6 | SM00133 | |
| Domain | - | 1.05e-06 | 39 | 88 | 5 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.20e-06 | 40 | 88 | 5 | IPR023415 | |
| Domain | EGF_3 | 1.63e-06 | 235 | 88 | 9 | PS50026 | |
| Domain | EGF | 1.63e-06 | 235 | 88 | 9 | SM00181 | |
| Domain | Ldl_recept_a | 2.18e-06 | 45 | 88 | 5 | PF00057 | |
| Domain | - | 2.44e-06 | 46 | 88 | 5 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.44e-06 | 46 | 88 | 5 | IPR011042 | |
| Domain | EGF-like_dom | 2.63e-06 | 249 | 88 | 9 | IPR000742 | |
| Domain | LDLRA_1 | 3.02e-06 | 48 | 88 | 5 | PS01209 | |
| Domain | EGF_1 | 3.20e-06 | 255 | 88 | 9 | PS00022 | |
| Domain | LDLRA_2 | 3.35e-06 | 49 | 88 | 5 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.35e-06 | 49 | 88 | 5 | IPR002172 | |
| Domain | LDLa | 3.35e-06 | 49 | 88 | 5 | SM00192 | |
| Domain | EGF-like_CS | 3.87e-06 | 261 | 88 | 9 | IPR013032 | |
| Domain | EGF_2 | 4.37e-06 | 265 | 88 | 9 | PS01186 | |
| Domain | HR1 | 5.56e-06 | 8 | 88 | 3 | PF02185 | |
| Domain | cEGF | 6.35e-06 | 26 | 88 | 4 | IPR026823 | |
| Domain | cEGF | 6.35e-06 | 26 | 88 | 4 | PF12662 | |
| Domain | EGF_Ca-bd_CS | 6.45e-06 | 97 | 88 | 6 | IPR018097 | |
| Domain | EGF_CA | 7.26e-06 | 99 | 88 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.70e-06 | 100 | 88 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.08e-05 | 106 | 88 | 6 | IPR000152 | |
| Domain | DUF5050 | 2.19e-05 | 2 | 88 | 2 | IPR032485 | |
| Domain | DUF5050 | 2.19e-05 | 2 | 88 | 2 | PF16472 | |
| Domain | EGF_CA | 2.40e-05 | 122 | 88 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.63e-05 | 124 | 88 | 6 | IPR001881 | |
| Domain | EGF_CA | 5.34e-05 | 86 | 88 | 5 | PF07645 | |
| Domain | PROTEIN_KINASE_ATP | 5.93e-05 | 459 | 88 | 10 | PS00107 | |
| Domain | CPT_N | 6.56e-05 | 3 | 88 | 2 | IPR032476 | |
| Domain | CPT_N | 6.56e-05 | 3 | 88 | 2 | PF16484 | |
| Domain | Prot_kinase_dom | 1.00e-04 | 489 | 88 | 10 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.07e-04 | 493 | 88 | 10 | PS50011 | |
| Domain | C1_1 | 1.50e-04 | 57 | 88 | 4 | PF00130 | |
| Domain | Choline_transpo | 2.17e-04 | 5 | 88 | 2 | PF04515 | |
| Domain | Choline_transptr-like | 2.17e-04 | 5 | 88 | 2 | IPR007603 | |
| Domain | - | 2.17e-04 | 5 | 88 | 2 | 1.10.287.160 | |
| Domain | Kinase-like_dom | 2.31e-04 | 542 | 88 | 10 | IPR011009 | |
| Domain | ZF_DAG_PE_1 | 2.36e-04 | 64 | 88 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 2.36e-04 | 64 | 88 | 4 | PS50081 | |
| Domain | C1 | 2.50e-04 | 65 | 88 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 2.65e-04 | 66 | 88 | 4 | IPR002219 | |
| Domain | - | 3.25e-04 | 6 | 88 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 3.25e-04 | 6 | 88 | 2 | PF00930 | |
| Domain | Peptidase_S9B_N | 3.25e-04 | 6 | 88 | 2 | IPR002469 | |
| Domain | Protein_kinase_ATP_BS | 4.18e-04 | 379 | 88 | 8 | IPR017441 | |
| Domain | Carn_acyltransf | 4.54e-04 | 7 | 88 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 4.54e-04 | 7 | 88 | 2 | PS00439 | |
| Domain | Carn_acyl_trans | 4.54e-04 | 7 | 88 | 2 | IPR000542 | |
| Domain | ACYLTRANSF_C_2 | 4.54e-04 | 7 | 88 | 2 | PS00440 | |
| Domain | Hr1 | 4.54e-04 | 7 | 88 | 2 | SM00742 | |
| Domain | - | 6.74e-04 | 148 | 88 | 5 | 2.60.40.150 | |
| Domain | TyrKc | 7.94e-04 | 88 | 88 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 7.94e-04 | 88 | 88 | 4 | IPR020635 | |
| Domain | Growth_fac_rcpt_ | 8.55e-04 | 156 | 88 | 5 | IPR009030 | |
| Domain | C2_dom | 1.07e-03 | 164 | 88 | 5 | IPR000008 | |
| Domain | PROTEIN_KINASE_TYR | 1.14e-03 | 97 | 88 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.14e-03 | 97 | 88 | 4 | IPR008266 | |
| Domain | Peptidase_S9 | 1.17e-03 | 11 | 88 | 2 | PF00326 | |
| Domain | XK_rel | 1.17e-03 | 11 | 88 | 2 | IPR018629 | |
| Domain | Tyr_kinase_rcpt_2_CS | 1.17e-03 | 11 | 88 | 2 | IPR002011 | |
| Domain | Peptidase_S9 | 1.17e-03 | 11 | 88 | 2 | IPR001375 | |
| Domain | XK-related | 1.17e-03 | 11 | 88 | 2 | PF09815 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.40e-03 | 12 | 88 | 2 | PS00239 | |
| Domain | - | 2.42e-03 | 119 | 88 | 4 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 2.42e-03 | 119 | 88 | 4 | IPR029058 | |
| Domain | EGF_extracell | 2.85e-03 | 60 | 88 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.85e-03 | 60 | 88 | 3 | PF07974 | |
| Domain | G_crystallin-rel | 3.20e-03 | 18 | 88 | 2 | IPR011024 | |
| Domain | Zn_pept | 3.20e-03 | 18 | 88 | 2 | SM00631 | |
| Domain | Pkinase_Tyr | 3.24e-03 | 129 | 88 | 4 | PF07714 | |
| Domain | CARBOXYPEPT_ZN_2 | 3.56e-03 | 19 | 88 | 2 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 3.95e-03 | 20 | 88 | 2 | PS00132 | |
| Domain | C2 | 4.01e-03 | 137 | 88 | 4 | SM00239 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.12e-03 | 138 | 88 | 4 | IPR001245 | |
| Domain | FA58C | 4.35e-03 | 21 | 88 | 2 | SM00231 | |
| Domain | DAG/PE-bd | 4.35e-03 | 21 | 88 | 2 | IPR020454 | |
| Domain | FA58C_3 | 4.35e-03 | 21 | 88 | 2 | PS50022 | |
| Domain | FA58C_1 | 4.35e-03 | 21 | 88 | 2 | PS01285 | |
| Domain | FA58C_2 | 4.35e-03 | 21 | 88 | 2 | PS01286 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | CETP CYB5R3 LRP1 LRP2 LRP4 LRP6 LBR DMBT1 CPT1A CPT1B LRP1B SH3BP4 | 7.19e-07 | 381 | 75 | 12 | M48063 |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.57e-06 | 74 | 75 | 6 | M41807 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.44e-05 | 70 | 75 | 5 | MM15597 | |
| Pathway | PID_RHOA_PATHWAY | 9.33e-05 | 45 | 75 | 4 | M12 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.39e-04 | 149 | 75 | 6 | M41805 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.56e-04 | 96 | 75 | 5 | M39581 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 3.34e-04 | 113 | 75 | 5 | M39669 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 3.44e-04 | 26 | 75 | 3 | MM14584 | |
| Pubmed | 5.59e-11 | 11 | 93 | 5 | 24639464 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 2.41e-09 | 21 | 93 | 5 | 21337463 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ROCK2 MEST BMP1 FAP ERO1B ROR2 CYB5R3 LRP1 LRP4 LRP6 LBR CPT1A SEC63 REEP5 LRP1B CTSZ MADD RNF170 | 2.70e-09 | 1201 | 93 | 18 | 35696571 |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.09e-08 | 101 | 93 | 7 | 23382219 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 19047013 | ||
| Pubmed | 4.72e-07 | 257 | 93 | 8 | 16335952 | ||
| Pubmed | Functional association of cytokine-induced SH2 protein and protein kinase C in activated T cells. | 6.43e-07 | 7 | 93 | 3 | 12618484 | |
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 23986861 | ||
| Pubmed | 1.69e-06 | 134 | 93 | 6 | 24658140 | ||
| Pubmed | In silico prediction of physical protein interactions and characterization of interactome orphans. | 1.85e-06 | 136 | 93 | 6 | 25402006 | |
| Pubmed | 6.60e-06 | 14 | 93 | 3 | 15082773 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 6.60e-06 | 14 | 93 | 3 | 17389516 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17089095 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 7.07e-06 | 2 | 93 | 2 | 15963947 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17620659 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18354190 | ||
| Pubmed | Diagnostic and clinical classification of autoimmune myasthenia gravis. | 7.07e-06 | 2 | 93 | 2 | 24530233 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27614059 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 8856079 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15272003 | ||
| Pubmed | Rapamycin-sensitive phosphorylation of PKC on a carboxy-terminal site by an atypical PKC complex. | 7.07e-06 | 2 | 93 | 2 | 10339425 | |
| Pubmed | Β-adrenergic-stimulated L-type channel Ca²+ entry mediates hypoxic Ca²+ overload in intact heart. | 7.07e-06 | 2 | 93 | 2 | 24041537 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9070950 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17786270 | ||
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 7.07e-06 | 2 | 93 | 2 | 26031789 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 34445520 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19117992 | ||
| Pubmed | Differential activation of adenylyl cyclase by protein kinase C isoenzymes. | 7.07e-06 | 2 | 93 | 2 | 8206971 | |
| Pubmed | Neuronal LRP4 regulates synapse formation in the developing CNS. | 7.07e-06 | 2 | 93 | 2 | 29061639 | |
| Pubmed | Mest/Peg1 inhibits Wnt signalling through regulation of LRP6 glycosylation. | 7.07e-06 | 2 | 93 | 2 | 21375506 | |
| Pubmed | Expression and regulation of carnitine palmitoyltransferase-Ialpha and -Ibeta genes. | 7.07e-06 | 2 | 93 | 2 | 10408760 | |
| Pubmed | Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2. | 7.07e-06 | 2 | 93 | 2 | 32314961 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30385274 | ||
| Pubmed | Cell-autonomous light sensitivity via Opsin3 regulates fuel utilization in brown adipocytes. | 7.07e-06 | 2 | 93 | 2 | 32040503 | |
| Pubmed | Molecular diagnosis of putative Stargardt disease by capture next generation sequencing. | 7.07e-06 | 2 | 93 | 2 | 24763286 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9013572 | ||
| Pubmed | MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. | 7.07e-06 | 2 | 93 | 2 | 24297891 | |
| Pubmed | 8.23e-06 | 15 | 93 | 3 | 12446192 | ||
| Pubmed | 1.01e-05 | 16 | 93 | 3 | 35714603 | ||
| Pubmed | 1.30e-05 | 191 | 93 | 6 | 31177093 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 28513615 | ||
| Pubmed | Isoforms of protein kinase C and their distribution in human adrenal cortex and tumors. | 2.12e-05 | 3 | 93 | 2 | 11740573 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 17974965 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 24244707 | ||
| Pubmed | Genomic structure of and a cardiac promoter for the mouse carnitine palmitoyltransferase II gene. | 2.12e-05 | 3 | 93 | 2 | 8307575 | |
| Pubmed | TrkB and protein kinase Mζ regulate synaptic localization of PSD-95 in developing cortex. | 2.12e-05 | 3 | 93 | 2 | 21849550 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 21969364 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 12643789 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 10617144 | ||
| Pubmed | BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes. | 2.12e-05 | 3 | 93 | 2 | 26796036 | |
| Pubmed | Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice. | 2.12e-05 | 3 | 93 | 2 | 16849539 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 11023836 | ||
| Pubmed | Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration. | 2.12e-05 | 3 | 93 | 2 | 21754995 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32496885 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 11841337 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 27919031 | ||
| Pubmed | Over-expression of protein kinase C isoforms (α, δ, θ and ζ) in squamous cervical cancer. | 2.12e-05 | 3 | 93 | 2 | 21895402 | |
| Pubmed | 2.38e-05 | 21 | 93 | 3 | 15452121 | ||
| Pubmed | The transcription factor Maz is essential for normal eye development. | 2.38e-05 | 21 | 93 | 3 | 32571845 | |
| Pubmed | 2.75e-05 | 22 | 93 | 3 | 24447338 | ||
| Pubmed | 2.75e-05 | 22 | 93 | 3 | 12871600 | ||
| Pubmed | Characterization of single-nucleotide polymorphisms in coding regions of human genes. | 3.23e-05 | 67 | 93 | 4 | 10391209 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 20093106 | ||
| Pubmed | KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. | 4.23e-05 | 4 | 93 | 2 | 18190796 | |
| Pubmed | Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. | 4.23e-05 | 4 | 93 | 2 | 20043068 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 12413896 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 21645497 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 34090516 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 7775583 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 14739301 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 15647998 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 23675446 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 28476658 | ||
| Pubmed | Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesis. | 4.23e-05 | 4 | 93 | 2 | 23651124 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 26253087 | ||
| Pubmed | Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. | 4.23e-05 | 4 | 93 | 2 | 21471202 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 15499829 | ||
| Pubmed | Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. | 4.23e-05 | 4 | 93 | 2 | 11095714 | |
| Pubmed | Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes. | 4.23e-05 | 4 | 93 | 2 | 8375396 | |
| Pubmed | Mest/Peg1 Is Essential for the Development and Maintenance of a SNc Neuronal Subset. | 4.23e-05 | 4 | 93 | 2 | 28133444 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 8830050 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 11781095 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 37356721 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 26041663 | ||
| Pubmed | Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2. | 4.23e-05 | 4 | 93 | 2 | 18215320 | |
| Pubmed | Expression of protein kinase C isoforms and interleukin-1beta in myofibrillar myopathy. | 4.23e-05 | 4 | 93 | 2 | 15159477 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 11421580 | ||
| Pubmed | Shh Plays an Inhibitory Role in Cusp Patterning by Regulation of Sostdc1. | 4.23e-05 | 4 | 93 | 2 | 30325689 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 10770950 | ||
| Pubmed | 6.38e-05 | 504 | 93 | 8 | 34432599 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 6.52e-05 | 372 | 93 | 7 | 22939624 | |
| Pubmed | 7.04e-05 | 5 | 93 | 2 | 17055779 | ||
| Pubmed | 7.04e-05 | 5 | 93 | 2 | 18667433 | ||
| Pubmed | 7.04e-05 | 5 | 93 | 2 | 20383322 | ||
| Pubmed | 7.04e-05 | 5 | 93 | 2 | 17283184 | ||
| Pubmed | Protein kinase C isoforms have differential roles in the regulation of human sebocyte biology. | 7.04e-05 | 5 | 93 | 2 | 22475757 | |
| Pubmed | 7.04e-05 | 5 | 93 | 2 | 15192100 | ||
| Pubmed | Characterization of PDK2 activity against protein kinase B gamma. | 7.04e-05 | 5 | 93 | 2 | 12162751 | |
| Pubmed | Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding. | 7.04e-05 | 5 | 93 | 2 | 16263759 | |
| Pubmed | 7.04e-05 | 5 | 93 | 2 | 2590242 | ||
| Interaction | RPN2 interactions | FLII ARL2 ABCA4 WWOX MACO1 ROR2 CYB5R3 PRKCZ LBR CPT1A SEC63 REEP5 CIT ELOVL2 | 7.00e-06 | 782 | 88 | 14 | int:RPN2 |
| Interaction | GPRASP1 interactions | 1.10e-05 | 67 | 88 | 5 | int:GPRASP1 | |
| Interaction | VSIG4 interactions | 1.39e-05 | 180 | 88 | 7 | int:VSIG4 | |
| Interaction | RHOA interactions | ROCK2 MEST MACO1 ROR2 LRP2 PRKCA FASTKD5 PKN2 PRKCZ LBR CPT1A SEC63 REEP5 CIT ELOVL2 PKN3 SH3BP4 | 1.44e-05 | 1199 | 88 | 17 | int:RHOA |
| Interaction | VDAC2 interactions | 1.88e-05 | 432 | 88 | 10 | int:VDAC2 | |
| Cytoband | 4p15.32 | 4.68e-04 | 16 | 92 | 2 | 4p15.32 | |
| GeneFamily | Low density lipoprotein receptors | 8.15e-10 | 13 | 68 | 5 | 634 | |
| GeneFamily | C2 domain containing protein kinases | 5.99e-06 | 10 | 68 | 3 | 835 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.51e-05 | 40 | 68 | 4 | 321 | |
| GeneFamily | CD molecules|DASH family | 2.89e-04 | 7 | 68 | 2 | 1205 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.49e-04 | 161 | 68 | 5 | 593 | |
| GeneFamily | Blood group antigens|XK related family | 7.50e-04 | 11 | 68 | 2 | 955 | |
| GeneFamily | Carboxypeptidases | 2.79e-03 | 21 | 68 | 2 | 1321 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | 5.39e-03 | 187 | 68 | 4 | 349 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 7.46e-06 | 409 | 88 | 10 | GSM605840_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 7.62e-06 | 410 | 88 | 10 | GSM854297_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 7.95e-06 | 412 | 88 | 10 | GSM605843_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | 8.47e-06 | 415 | 88 | 10 | GSM854299_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | ZMYND15 BMP1 VIPR1 PIGB NTNG2 WWOX GLP1R MID1 LRP4 PRKCA ADTRP | 4.74e-05 | 616 | 88 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SELL CACNA1A PROM1 NTNG2 SLF1 WWOX NTRK2 MID1 LRP2 XKR8 CPT1B CIT DSCAML1 XKR5 ELOVL2 MADD ENOX2 | 6.04e-05 | 1414 | 88 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-07 | 192 | 91 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 167 | 91 | 6 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 167 | 91 | 6 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 179 | 91 | 6 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | Immune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class | 2.02e-06 | 182 | 91 | 6 | 99c7d4f1e7cd745643ba64b59190113bcd4e348e | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.44e-06 | 188 | 91 | 6 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 195 | 91 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-06 | 195 | 91 | 6 | 4d7ca21f14730e1b6d0473bc1a11aa626db948f3 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-06 | 195 | 91 | 6 | 8727554ef047ca7f1d4b888a8468f148c64a6918 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-epithelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 195 | 91 | 6 | 9f0ee826d4f0997aee8d63284ed24549bbdf6a28 | |
| ToppCell | cellseq2-Epithelial|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-06 | 199 | 91 | 6 | 2d4fb558845764f937efaf39962caaeb2c85478b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-06 | 199 | 91 | 6 | ca78fd6e310232b25b864ed02ff9242fe1aa8206 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-06 | 199 | 91 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 3.48e-06 | 200 | 91 | 6 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 3.48e-06 | 200 | 91 | 6 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 157 | 91 | 5 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 157 | 91 | 5 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 164 | 91 | 5 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 2.25e-05 | 165 | 91 | 5 | 1776e7db80d7cf6b449fa8635a111705a59231b4 | |
| ToppCell | Club-club-2|World / Class top | 2.32e-05 | 166 | 91 | 5 | 56f11efb6b686b3ee2c34a051f626e3d761b5112 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 2.38e-05 | 167 | 91 | 5 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | facs-Large_Intestine-Proximal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | 23e0e1592d7400012d289adb10c7598285bae2e9 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 170 | 91 | 5 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 2.67e-05 | 171 | 91 | 5 | 3ecd0a074344179c57eb2d9a857ba594904d00fa | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 172 | 91 | 5 | 24ecfda5e43e28f190089770cd2eae5bf2ed292b | |
| ToppCell | Club-club-3|World / Class top | 2.75e-05 | 172 | 91 | 5 | 34fbb82a2ec77dd183cf26b38edeb7e936b707bc | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 172 | 91 | 5 | db5a31cafce4346fe459d7f35210823fd7004439 | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 2.75e-05 | 172 | 91 | 5 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 173 | 91 | 5 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 173 | 91 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 173 | 91 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 173 | 91 | 5 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 174 | 91 | 5 | 919fc124affc69acfd8f575f2c372674f3d2625e | |
| ToppCell | COVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 175 | 91 | 5 | 4c35292ad2ac712ba7516f27dd6eac6ba8fdd163 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 176 | 91 | 5 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 176 | 91 | 5 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP|lymph-node_spleen / Manually curated celltypes from each tissue | 3.07e-05 | 176 | 91 | 5 | 23a8ec42ebd42c539865a12d09773af90f3f8848 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-05 | 177 | 91 | 5 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 177 | 91 | 5 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 3.15e-05 | 177 | 91 | 5 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 180 | 91 | 5 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 180 | 91 | 5 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 180 | 91 | 5 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 181 | 91 | 5 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-05 | 181 | 91 | 5 | a2c03bd7adc4a65f3b373c229ec0ecc84f724b17 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 181 | 91 | 5 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 181 | 91 | 5 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-05 | 181 | 91 | 5 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 181 | 91 | 5 | e6c78038b14100e0c9c6fe25e8f0b75c02c33549 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-mature_NK_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-05 | 181 | 91 | 5 | c073e6c917354528ac5bad88a226e1134004ba43 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 181 | 91 | 5 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 181 | 91 | 5 | 0069e8308de932df43660bbe926637c57b8bf7f6 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.60e-05 | 182 | 91 | 5 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 182 | 91 | 5 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 182 | 91 | 5 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_2|World / Lineage and Cell class | 3.60e-05 | 182 | 91 | 5 | a7e7aa10f14111a6c7ba22e0f1668dcaa124714d | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.69e-05 | 183 | 91 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 183 | 91 | 5 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.69e-05 | 183 | 91 | 5 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 183 | 91 | 5 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 3.79e-05 | 184 | 91 | 5 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 3.89e-05 | 185 | 91 | 5 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.89e-05 | 185 | 91 | 5 | 2c07991e0907ded67e21ab2e66be21695842ed01 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.99e-05 | 186 | 91 | 5 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 186 | 91 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | 1387981d224cb9e846ed18e366736855a4eb827e | |
| ToppCell | facs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 188 | 91 | 5 | 7da9750255efbc5cf9aed7e3105a337fac63b9f0 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.31e-05 | 189 | 91 | 5 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 190 | 91 | 5 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 190 | 91 | 5 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 190 | 91 | 5 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 190 | 91 | 5 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-05 | 191 | 91 | 5 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 4.53e-05 | 191 | 91 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|World / Lineage, cell class and subclass | 4.53e-05 | 191 | 91 | 5 | 91bbc9d3a9ecc49262060faeb0047764828c1960 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-05 | 191 | 91 | 5 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 191 | 91 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|World / Lineage, cell class and subclass | 4.53e-05 | 191 | 91 | 5 | b71dc4e27a22955926547493fc959afc20208566 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.53e-05 | 191 | 91 | 5 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-05 | 192 | 91 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 4.64e-05 | 192 | 91 | 5 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 192 | 91 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 91 | 5 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 91 | 5 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.76e-05 | 193 | 91 | 5 | b9dcffd28ca309359fb110fb79de8ce066208ee1 | |
| Drug | mangrove | CETP LRP1 LRP2 LRP4 LRP6 PRKCA PKN2 PRKCZ CPT1A CPT1B LRP1B F7 MUSK PKN3 PLIN2 | 3.75e-10 | 468 | 89 | 15 | CID000000965 |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; PC3; HT_HG-U133A | 8.27e-08 | 198 | 89 | 9 | 5875_UP | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 8.27e-08 | 198 | 89 | 9 | 5470_DN | |
| Drug | monatepil | 8.98e-08 | 29 | 89 | 5 | CID000060810 | |
| Drug | vitamin E | CACNA1A CETP LRP1 LRP2 LRP4 LRP6 PRKCA PKN2 PRKCZ LRP1B MUSK PKN3 | 1.48e-07 | 441 | 89 | 12 | CID000002116 |
| Drug | epicholesterol | ABCA4 ADRB1 CETP LRP1 LRP2 LRP4 LRP6 LBR CPT1A LRP1B F7 F11 MUSK PLIN2 | 1.69e-07 | 636 | 89 | 14 | CID000000304 |
| Drug | puerarin | 1.71e-07 | 63 | 89 | 6 | CID005281807 | |
| Drug | RK-1409B | 2.88e-07 | 15 | 89 | 4 | CID003036125 | |
| Drug | dansyl-DAG | 2.88e-07 | 15 | 89 | 4 | CID000129493 | |
| Drug | pitavastatin | 3.22e-07 | 114 | 89 | 7 | CID005282451 | |
| Drug | tautomycin | 4.07e-07 | 118 | 89 | 7 | CID000440646 | |
| Drug | daphnoretin | 4.99e-07 | 17 | 89 | 4 | CID005281406 | |
| Drug | dihydrosterculic acid | 6.40e-07 | 18 | 89 | 4 | CID000160788 | |
| Drug | TAPP-Br | 8.08e-07 | 19 | 89 | 4 | CID000160326 | |
| Drug | acetyl-L-carnitine | 9.57e-07 | 84 | 89 | 6 | CID000000001 | |
| Drug | NPC 15437 | 9.84e-07 | 46 | 89 | 5 | CID000004548 | |
| Drug | KS-619-1 | 1.24e-06 | 21 | 89 | 4 | CID000128369 | |
| Drug | K-259-2 | 1.24e-06 | 21 | 89 | 4 | CID006438946 | |
| Drug | broussochalcone A | 1.24e-06 | 21 | 89 | 4 | CID006438825 | |
| Drug | eicosa-8,11,14-trienoic acid | 1.26e-06 | 88 | 89 | 6 | CID000003011 | |
| Drug | clozapine | 1.27e-06 | 274 | 89 | 9 | CID000002818 | |
| Drug | thiamylal | 1.36e-06 | 49 | 89 | 5 | CID003032285 | |
| Drug | 9,11-octadecadienoic acid | 1.42e-06 | 142 | 89 | 7 | CID000074607 | |
| Drug | mepivacaine | 1.66e-06 | 51 | 89 | 5 | CID000004062 | |
| Drug | BiM4 | 1.66e-06 | 283 | 89 | 9 | CID000002399 | |
| Drug | ezetimibe | 1.79e-06 | 147 | 89 | 7 | CID000150311 | |
| Drug | Coagulation Factor IX | 2.00e-06 | 7 | 89 | 3 | DB00100 | |
| Drug | palmitoylcarnitine | 3.00e-06 | 102 | 89 | 6 | CID000000461 | |
| Drug | aldosterone | 3.47e-06 | 397 | 89 | 10 | CID000005839 | |
| Drug | pseudohypericin | 3.57e-06 | 27 | 89 | 4 | CID005281751 | |
| Drug | nsc25485 | 3.69e-06 | 312 | 89 | 9 | CID000004605 | |
| Drug | aplysiatoxin | 4.16e-06 | 28 | 89 | 4 | CID000040465 | |
| Drug | coprogen | 4.77e-06 | 9 | 89 | 3 | CID006323272 | |
| Drug | Polychlorinated biphenyls | 4.81e-06 | 29 | 89 | 4 | CID000006636 | |
| Drug | PDBu | 6.02e-06 | 249 | 89 | 8 | CID000037783 | |
| Drug | ethoxytriethyleneglycol | 6.03e-06 | 66 | 89 | 5 | CID000008190 | |
| Drug | poly I | 6.20e-06 | 250 | 89 | 8 | CID000000797 | |
| Drug | Nicorette | ROCK2 CACNA1A BMP1 FLII ADRB1 NTRK2 PRKCA PKN2 PRKCZ MUSK PKN3 | 6.83e-06 | 529 | 89 | 11 | CID000000942 |
| Drug | cyanide | 6.96e-06 | 254 | 89 | 8 | CID000000768 | |
| Drug | AC1L1ERT | 7.52e-06 | 69 | 89 | 5 | CID000002920 | |
| Drug | sodium linoleate | 7.75e-06 | 342 | 89 | 9 | CID000003931 | |
| Drug | AC1L1FGW | 8.18e-06 | 33 | 89 | 4 | CID000003231 | |
| Drug | A61603 | 8.18e-06 | 33 | 89 | 4 | CID004038180 | |
| Drug | procyanidin | 8.66e-06 | 71 | 89 | 5 | CID000107876 | |
| Drug | N-methyl-DL-aspartic acid | CACNA1A FLII NTNG2 NTRK2 LRP1 PRKCA PKN2 PRKCZ CABIN1 CIT F11 PKN3 | 9.13e-06 | 655 | 89 | 12 | CID000004376 |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.16e-05 | 195 | 89 | 7 | 6718_UP | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.16e-05 | 195 | 89 | 7 | 4073_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; PC3; HT_HG-U133A | 1.19e-05 | 196 | 89 | 7 | 4664_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.19e-05 | 196 | 89 | 7 | 2158_DN | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; PC3; HT_HG-U133A | 1.23e-05 | 197 | 89 | 7 | 6747_UP | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 7294_UP | |
| Drug | Azaperone [1649-18-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 5877_UP | |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 1690_DN | |
| Drug | norathyriol | 1.31e-05 | 37 | 89 | 4 | CID005281656 | |
| Drug | 6,9,12-octadecatrienoic acid | 1.37e-05 | 78 | 89 | 5 | CID000003453 | |
| Drug | AC1MU1S9 | SELL ROCK2 LRP1 PRKCA SLA2 PKN2 TRIM39 PRKCZ CPT1B CABIN1 PKN3 | 1.42e-05 | 572 | 89 | 11 | CID000003733 |
| Drug | U46619 | 1.61e-05 | 285 | 89 | 8 | CID000005618 | |
| Drug | vasopressin | 2.11e-05 | 388 | 89 | 9 | CID011979316 | |
| Drug | antibiotic from Streptomyces | 2.18e-05 | 42 | 89 | 4 | CID000005153 | |
| Drug | benzenesulfonate | 2.18e-05 | 42 | 89 | 4 | CID000007371 | |
| Drug | D-6069 | 2.18e-05 | 42 | 89 | 4 | CID000181664 | |
| Drug | SC-9 | 2.40e-05 | 43 | 89 | 4 | CID000124172 | |
| Drug | benzoyl | 2.40e-05 | 43 | 89 | 4 | CID000007187 | |
| Drug | AC1LDMDX | 2.40e-05 | 43 | 89 | 4 | CID000621355 | |
| Drug | pentobarbital | 2.82e-05 | 224 | 89 | 7 | CID000004737 | |
| Drug | procyanidin B2 | 2.88e-05 | 45 | 89 | 4 | CID000122738 | |
| Drug | myricitrin | 2.88e-05 | 45 | 89 | 4 | CID005281673 | |
| Drug | C-1A | 2.91e-05 | 91 | 89 | 5 | CID009543473 | |
| Drug | procaine | 3.06e-05 | 153 | 89 | 6 | CID000004914 | |
| Drug | DAPs | 3.07e-05 | 92 | 89 | 5 | CID000146339 | |
| Drug | triphenylethylene | 3.14e-05 | 46 | 89 | 4 | CID000006025 | |
| Drug | calmidazolium chloride | 3.94e-05 | 160 | 89 | 6 | CID000002531 | |
| Drug | 25-hydroxycholesterol | 3.94e-05 | 160 | 89 | 6 | CID000065094 | |
| Drug | 1,2-dicaprin | 4.04e-05 | 49 | 89 | 4 | CID000001321 | |
| Drug | NSC150531 | 4.04e-05 | 49 | 89 | 4 | CID000004475 | |
| Drug | 17alpha-estradiol | CACNA1A ADRB1 WWOX SRD5A2 LRP1 LRP2 LRP4 LRP6 PRKCA PKN2 PRKCZ SKAP2 LRP1B F7 F11 MUSK | 4.06e-05 | 1303 | 89 | 16 | CID000000450 |
| Drug | probucol | 4.22e-05 | 162 | 89 | 6 | CID000004912 | |
| Drug | thiomalate | 4.38e-05 | 50 | 89 | 4 | CID000006268 | |
| Drug | buformin | 4.52e-05 | 18 | 89 | 3 | CID000002468 | |
| Drug | perfluorobutane | 4.52e-05 | 18 | 89 | 3 | ctd:C108042 | |
| Drug | DB08434 | 4.52e-05 | 3 | 89 | 2 | CID005289220 | |
| Drug | tetradotoxin | 4.54e-05 | 428 | 89 | 9 | CID000020382 | |
| Drug | 9,12,15-octadecatrienoic acid | 5.00e-05 | 167 | 89 | 6 | CID000000860 | |
| Drug | N-desmethyl-tamoxifen-hydrochloride | 5.12e-05 | 52 | 89 | 4 | CID000035887 | |
| Drug | NSC226080 | ROCK2 SELENBP1 CETP NTRK2 ROR2 LRP1 LRP6 PRKCA PKN2 PRKCZ CABIN1 PKN3 | 5.20e-05 | 782 | 89 | 12 | CID000005040 |
| Drug | DB04780 | 5.52e-05 | 170 | 89 | 6 | CID005459389 | |
| Drug | hydroxyl radicals | ABCA4 MID1 ENTPD5 LRP1 LRP2 LRP6 PRKCA PKN2 PRKCZ LBR ATP12A LRP1B CIT F7 F11 PKN3 | 5.72e-05 | 1341 | 89 | 16 | CID000000961 |
| Drug | loperamide | 5.78e-05 | 105 | 89 | 5 | CID000003954 | |
| Drug | CGP 19835A | 5.94e-05 | 54 | 89 | 4 | CID005479141 | |
| Drug | Y-27632 | 6.02e-05 | 444 | 89 | 9 | CID000005711 | |
| Drug | 20-HETE | 6.05e-05 | 106 | 89 | 5 | CID005283157 | |
| Drug | AD 198 | 6.27e-05 | 20 | 89 | 3 | CID000127201 | |
| Drug | 26 C | 7.30e-05 | 21 | 89 | 3 | CID005327159 | |
| Drug | butenal | 7.58e-05 | 180 | 89 | 6 | CID000020138 | |
| Drug | carbachol | ROCK2 CACNA1A VIPR1 ADRB1 PRKCA SLA2 PKN2 PRKCZ LBR CPT1B PKN3 | 7.61e-05 | 688 | 89 | 11 | CID000002551 |
| Drug | thiopental | 7.87e-05 | 112 | 89 | 5 | CID003000715 | |
| Drug | chelerythrine | 7.91e-05 | 357 | 89 | 8 | CID000002703 | |
| Drug | sterol | 8.17e-05 | 265 | 89 | 7 | CID000001107 | |
| Drug | Lucifer yellow | 8.21e-05 | 113 | 89 | 5 | CID006335488 | |
| Drug | AC1NS5LF | 8.43e-05 | 22 | 89 | 3 | CID005354434 | |
| Disease | Cardiomegaly | 5.06e-06 | 82 | 89 | 5 | C0018800 | |
| Disease | Cardiac Hypertrophy | 5.06e-06 | 82 | 89 | 5 | C1383860 | |
| Disease | epilepsy (implicated_via_orthology) | 1.03e-05 | 163 | 89 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.73e-05 | 51 | 89 | 4 | EFO_0022285 | |
| Disease | Stargardt disease | 2.69e-05 | 3 | 89 | 2 | cv:C0271093 | |
| Disease | lysophosphatidylcholine measurement | 3.77e-05 | 62 | 89 | 4 | EFO_0010224 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 4.50e-05 | 23 | 89 | 3 | EFO_0004286, EFO_0004791 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 6.56e-05 | 26 | 89 | 3 | DOID:9351 (implicated_via_orthology) | |
| Disease | fatty acid measurement, docosapentaenoic acid measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0005110, EFO_0006809 | |
| Disease | phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0800467 | |
| Disease | STARGARDT DISEASE 1 (disorder) | 8.94e-05 | 5 | 89 | 2 | C1855465 | |
| Disease | factor XI measurement, venous thromboembolism | 1.02e-04 | 30 | 89 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.12e-04 | 31 | 89 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | cholesteryl ester 22:6 measurement | 1.23e-04 | 32 | 89 | 3 | EFO_0010350 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:2) in blood serum | 1.34e-04 | 6 | 89 | 2 | OBA_2045134 | |
| Disease | level of Phosphatidylcholine (O-16:0_18:2) in blood serum | 1.34e-04 | 6 | 89 | 2 | OBA_2045114 | |
| Disease | Stargardt's disease | 1.34e-04 | 6 | 89 | 2 | C0271093 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.48e-04 | 34 | 89 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | COVID-19, mortality | 1.68e-04 | 170 | 89 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.87e-04 | 7 | 89 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement | 1.87e-04 | 7 | 89 | 2 | EFO_0800391 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.87e-04 | 7 | 89 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0800610 | |
| Disease | protein FAM177A1 measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0801948 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0800396 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0800392 | |
| Disease | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0800455 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0800423 | |
| Disease | 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0800420 | |
| Disease | Colorectal Carcinoma | 2.71e-04 | 702 | 89 | 9 | C0009402 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 3.19e-04 | 9 | 89 | 2 | EFO_0800517 | |
| Disease | Schizophrenia | CNPPD1 DDR1 NTNG2 SELENBP1 NTRK2 SRD5A2 LRP1 LRP2 PRKCA FASTKD5 | 3.29e-04 | 883 | 89 | 10 | C0036341 |
| Disease | aspartate aminotransferase measurement | 3.96e-04 | 904 | 89 | 10 | EFO_0004736 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 3.98e-04 | 10 | 89 | 2 | OBA_2045132 | |
| Disease | testosterone measurement | DDR1 NTNG2 WWOX MACO1 WNT2B SRD5A2 ZNF316 DNAH2 PRKCA ATP12A PKN3 PLIN2 | 4.42e-04 | 1275 | 89 | 12 | EFO_0004908 |
| Disease | Polydactyly | 4.42e-04 | 117 | 89 | 4 | C0152427 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 4.69e-04 | 50 | 89 | 3 | EFO_0022303 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 4.86e-04 | 11 | 89 | 2 | OBA_2045197 | |
| Disease | serum metabolite measurement | 5.60e-04 | 945 | 89 | 10 | EFO_0005653 | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 5.82e-04 | 12 | 89 | 2 | EFO_0800544 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 5.82e-04 | 12 | 89 | 2 | EFO_0800466 | |
| Disease | hair morphology measurement | 5.89e-04 | 54 | 89 | 3 | EFO_0007821 | |
| Disease | docosahexaenoic acid measurement | 6.02e-04 | 127 | 89 | 4 | EFO_0007761 | |
| Disease | ecosanoids measurement | 6.21e-04 | 55 | 89 | 3 | EFO_0020044 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 6.21e-04 | 55 | 89 | 3 | EFO_0022288 | |
| Disease | calcium measurement | 6.26e-04 | 628 | 89 | 8 | EFO_0004838 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 6.87e-04 | 13 | 89 | 2 | OBA_2045072 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 7.98e-04 | 239 | 89 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 8.00e-04 | 14 | 89 | 2 | OBA_2045100 | |
| Disease | lysophosphatidylcholine 22:5 measurement | 8.00e-04 | 14 | 89 | 2 | EFO_0021462 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 8.02e-04 | 60 | 89 | 3 | EFO_0022282 | |
| Disease | type 1 diabetes mellitus | 8.44e-04 | 242 | 89 | 5 | MONDO_0005147 | |
| Disease | phospholipid measurement | 8.67e-04 | 140 | 89 | 4 | EFO_0004639 | |
| Disease | apolipoprotein B measurement | 8.90e-04 | 663 | 89 | 8 | EFO_0004615 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 9.21e-04 | 15 | 89 | 2 | OBA_2045131 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 9.21e-04 | 15 | 89 | 2 | OBA_2045067 | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 9.21e-04 | 15 | 89 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 1.05e-03 | 16 | 89 | 2 | OBA_2045090 | |
| Disease | total lipids in very large HDL measurement | 1.06e-03 | 66 | 89 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 1.06e-03 | 66 | 89 | 3 | EFO_0022298 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.11e-03 | 67 | 89 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | fatty acid measurement, linoleic acid measurement | 1.15e-03 | 68 | 89 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | ovarian cancer (is_marker_for) | 1.15e-03 | 68 | 89 | 3 | DOID:2394 (is_marker_for) | |
| Disease | hyperglycemia (implicated_via_orthology) | 1.19e-03 | 17 | 89 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 1.19e-03 | 17 | 89 | 2 | OBA_2045063 | |
| Disease | cholesterol in very large HDL measurement | 1.20e-03 | 69 | 89 | 3 | EFO_0022229 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.24e-03 | 264 | 89 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | anorexia nervosa | 1.25e-03 | 70 | 89 | 3 | MONDO_0005351 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 1.33e-03 | 18 | 89 | 2 | EFO_0010365 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.33e-03 | 18 | 89 | 2 | OBA_2045065 | |
| Disease | lymphocyte count | ROCK2 FAP ADRB1 WWOX SELENBP1 OPN3 PKN2 DMBT1 ADTRP TM6SF1 SKAP2 CTSZ | 1.47e-03 | 1464 | 89 | 12 | EFO_0004587 |
| Disease | diabetes mellitus (biomarker_via_orthology) | 1.49e-03 | 19 | 89 | 2 | DOID:9351 (biomarker_via_orthology) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.49e-03 | 19 | 89 | 2 | EFO_0802076 | |
| Disease | diacylglycerol 38:5 measurement | 1.49e-03 | 19 | 89 | 2 | EFO_0020067 | |
| Disease | reasoning | 1.49e-03 | 19 | 89 | 2 | EFO_0004350 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.51e-03 | 276 | 89 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 1.65e-03 | 20 | 89 | 2 | OBA_2045071 | |
| Disease | phosphatidylcholine measurement | 1.71e-03 | 284 | 89 | 5 | EFO_0010226 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.71e-03 | 78 | 89 | 3 | EFO_0022187 | |
| Disease | high density lipoprotein particle size measurement | 1.77e-03 | 170 | 89 | 4 | EFO_0008592 | |
| Disease | free cholesterol in large HDL measurement | 1.78e-03 | 79 | 89 | 3 | EFO_0022157 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 1.82e-03 | 21 | 89 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 1.82e-03 | 21 | 89 | 2 | OBA_2045083 | |
| Disease | daytime rest measurement | 2.02e-03 | 295 | 89 | 5 | EFO_0007828 | |
| Disease | fatty acid measurement | 2.08e-03 | 436 | 89 | 6 | EFO_0005110 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 2.18e-03 | 23 | 89 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.27e-03 | 303 | 89 | 5 | EFO_0004612, EFO_0020945 | |
| Disease | Liver Cirrhosis, Experimental | 2.36e-03 | 774 | 89 | 8 | C0023893 | |
| Disease | Myasthenic Syndromes, Congenital | 2.38e-03 | 24 | 89 | 2 | C0751882 | |
| Disease | HDL cholesterol change measurement | 2.38e-03 | 24 | 89 | 2 | EFO_0007805 | |
| Disease | Dyslipidemias | 2.38e-03 | 24 | 89 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.38e-03 | 24 | 89 | 2 | C0598784 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.40e-03 | 307 | 89 | 5 | EFO_0004612, EFO_0020946 | |
| Disease | coronary artery calcification | 2.44e-03 | 450 | 89 | 6 | EFO_0004723 | |
| Disease | Prostatic Neoplasms | 2.63e-03 | 616 | 89 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.63e-03 | 616 | 89 | 7 | C0376358 | |
| Disease | Hypertensive disease | 2.66e-03 | 190 | 89 | 4 | C0020538 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.66e-03 | 91 | 89 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.68e-03 | 315 | 89 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | venous thromboembolism | 2.72e-03 | 460 | 89 | 6 | EFO_0004286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVRVWAEYDPAAWGR | 1831 | O00555 | |
| ATIVVWGRWEYGSFF | 116 | P08588 | |
| YGYTTAWWLGIDQSI | 116 | P11597 | |
| AGWGISDGTEYWIVR | 246 | Q9UBR2 | |
| WYFLLQESYWLGGEG | 871 | P78363 | |
| ELRVWPGYDYVGWSN | 246 | Q08345 | |
| RYTGYKGTSAWRVWN | 186 | Q86YB8 | |
| YISRILWLYFETGTW | 166 | Q96IZ2 | |
| YVSDWWEEYIYLRGR | 231 | P50416 | |
| GRNSVWRYDWVTSYK | 191 | Q96SM3 | |
| VTETYYPTVWCWEGR | 76 | Q8WU67 | |
| YLRESGWYWGSITAS | 76 | Q9NSE2 | |
| WLGVFAGSWLVYVHY | 36 | Q5VUD6 | |
| WYDYVEVRDGFWRKA | 376 | P13497 | |
| NIDGYIYTWTTDRLW | 151 | Q8IVL8 | |
| WWSVGVIAYEMIYGR | 286 | O14578 | |
| TRTGELYTWGWGKYG | 316 | A6NED2 | |
| WYTLDRAPEAWDYGQ | 236 | P00387 | |
| YELWETRVFGVYLLW | 251 | Q14739 | |
| YWRNYFESTDGLIWV | 76 | P36404 | |
| WLEAEWIFGGVKYQY | 276 | O75356 | |
| DDSGSLNWEIYYWIG | 536 | Q13045 | |
| LNWEIYYWIGGEATL | 541 | Q13045 | |
| WVSLISWDGGSTYYA | 66 | P0DP04 | |
| SLYGSEVYWTDWRTN | 1476 | Q9NZR2 | |
| VEGLAYHRAWDTLYW | 2271 | Q9NZR2 | |
| LAVYDNYIFWSDWGR | 2411 | Q9NZR2 | |
| VLRSNIGTVYERWWY | 1466 | Q8WXG6 | |
| SEQWIFRLYVSIGWG | 261 | P43220 | |
| LYGGEVYWTDWRTNT | 1486 | Q07954 | |
| EGLAYHRGWDTLYWT | 2286 | Q07954 | |
| VVDVQNGYLYWTDWG | 3151 | Q07954 | |
| WTRYQREYLEWTGYT | 921 | P54707 | |
| RWLWVYEIGYAADNS | 6 | Q16206 | |
| GSISSGDYYWSWIRQ | 46 | P0DP06 | |
| TYVWVQYVWHTERGV | 106 | Q8N5G2 | |
| LGDYVYWTDWQRRSI | 541 | O75581 | |
| YYWIGIRKIGGIWTW | 86 | P14151 | |
| IDWVGRNLYWTDYAL | 1516 | P98164 | |
| YWADWGHRAYIGRVG | 3336 | P98164 | |
| GLEWLGRTYYRSKWY | 66 | A0A0B4J1U7 | |
| WVSLISWDGGSTYYA | 66 | A0A0B4J1X8 | |
| RAITYIWLYSLAWAG | 156 | Q9H1Y3 | |
| QGRWRGWYTYTDLCV | 196 | Q9BV87 | |
| ARLGYRVVELSYWEW | 726 | Q7L8L6 | |
| TAYVLTWEQGRYLIW | 1396 | Q9P2K1 | |
| FEDGWLEFVVRVYWL | 606 | Q9Y6J0 | |
| GEADIRVAKVLWWYY | 106 | Q9NXB9 | |
| YIARAGWTRDGKYAW | 351 | Q86TI2 | |
| YRVIFWSLYVDGEWG | 1126 | Q8TD84 | |
| YWLLAGIVLHGYARW | 1746 | Q12873 | |
| YTDCWVTGWGYRKLR | 511 | P03951 | |
| QYILERGEYPSWDAW | 66 | P53673 | |
| EDYTVSWYWIIIGLV | 226 | Q8IWA5 | |
| GLKVFEDYARTWYWI | 231 | Q8NCS7 | |
| EDYARTWYWILIGLT | 236 | Q8NCS7 | |
| VLYRGSWGTVCDDYW | 1266 | Q9UGM3 | |
| LIRLWIDYGFWYDRT | 2501 | Q9P225 | |
| SSYDWYKIWEGLTLR | 81 | Q5EB52 | |
| DWWEEYIYLRGRSPL | 236 | Q92523 | |
| YTRAVDWWGLGVLLY | 736 | Q6P5Z2 | |
| EGLATYWQSITWSRY | 101 | Q96CW9 | |
| YGYLTWEWTERLRSY | 101 | Q92521 | |
| TGYWRVRLWNGDKYA | 426 | Q9HCM9 | |
| GDWWTVLSEVSGREY | 66 | Q9H6Q3 | |
| HLYVLDTSGGEWWYA | 81 | Q9P0V3 | |
| GKSVDWWAYGVLLYE | 516 | P17252 | |
| ILSKEYNRYGWWVGE | 326 | O75563 | |
| HYRGTWYLTGIVSWG | 411 | P08709 | |
| YDYGRWLVVVTGWTL | 146 | P03923 | |
| TLEEYDSYWWLGGLV | 426 | O43490 | |
| IIAYWRYGSWLGAIS | 111 | Q96K19 | |
| AGLYGSHLYVWDWQR | 221 | Q13228 | |
| WLTYWVVYGVFSIAE | 86 | Q00765 | |
| WSYGVVLWEVFSYGL | 676 | Q01974 | |
| WSWTLGAVEILDSYY | 291 | P08514 | |
| ETSYTRAVDWWGLGV | 831 | Q16513 | |
| VEGLWYLTGIVSWGD | 246 | Q16651 | |
| VWSLGVVLWEIFTYG | 736 | Q16620 | |
| KRIAIWGWSYGGYVS | 616 | Q12884 | |
| ERKYFWGYILIGWGV | 251 | P32241 | |
| VWGIGYDHTAWVYTG | 781 | Q7Z6L1 | |
| HYWEVVISGSTWYAI | 541 | O15344 | |
| RTDIVSWFGDTRYAW | 701 | Q9UKY1 | |
| YGRECDWWSVGVFLY | 271 | O75116 | |
| GWEERTTKDGWVYYA | 21 | Q9NZC7 | |
| VVVGSWWYRSIRYSG | 206 | Q9UGP8 | |
| WWYRSIRYSGDQILI | 211 | Q9UGP8 | |
| GEIIEWIGYALATWS | 196 | P31213 | |
| IQGFTIWTCWDYGIY | 3476 | Q86WI1 | |
| RWLDETTYEWGYKIE | 81 | Q9BQI6 | |
| EGDIVTGVYTGAWFW | 226 | A6NFI3 | |
| LYLSWVEWKRSIGYD | 281 | Q99541 | |
| YYFTTGRLLWGWLAL | 26 | Q6UX68 | |
| RGVFGSWQDYYTWRG | 456 | Q9H091 | |
| SWQDYYTWRGLSLDS | 461 | Q9H091 | |
| VDTSWWYIGALGARV | 56 | Q93097 | |
| WDESTAAYGYWFKGR | 51 | A6NMB1 | |
| AWEETYRTIGLYWVG | 131 | Q9BZW5 | |
| LWAAVQYALGGRYLW | 31 | Q9H6D3 | |
| EILRGEEYGFSVDWW | 421 | Q05513 | |
| EEYGFSVDWWALGVL | 426 | Q05513 | |
| LTLYGERIYWTDWQT | 951 | O75096 | |
| YGLTLLDSYIYWTDW | 1256 | O75096 | |
| WAYGVVLWEIFSYGL | 786 | O15146 |